Empyrean Capital Partners’s Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-300,000
Closed -$135K 193
2022
Q1
$135K Hold
300,000
﹤0.01% 180
2021
Q4
$309K Hold
300,000
0.01% 164
2021
Q3
$279K Buy
+300,000
New +$352K 0.01% 174

Other funds holding WPCB.WS

Empyrean Capital Partners's WPCB.WS Position: Q2 2022 in Review

Empyrean Capital Partners sold out of Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCB.WS) in Q2 2022, closing a stake of 300,000 shares — an estimated $135K sold.

Empyrean Capital Partners first reported a position in WPCB.WS in Q3 2021 and held it in 3 quarters. The position peaked at $309K in Q4 2021. 51 funds tracked by Wall St. Rank hold WPCB.WS as of Q2 2022.

  • Empyrean Capital Partners reported no remaining Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • Empyrean Capital Partners sold 300,000 Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $135K.
  • Empyrean Capital Partners first reported a position in Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 3 quarters.
  • Empyrean Capital Partners's Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $309K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.